MAPT and Alzheimer disease: Similarly, mouse models of AD have shown that deletion of the GRN gene increases Aβ deposition, intracellular tau accumulation, and microglial activation, whereas PGRN overexpression exerts neuroprotective effects, reduces plaque formation, and improves memory [100].